StockGuru Blog: The Immune Response Corporation About IR103 and How It Works
IMNR - The Immune Response Corporation More than 25 million people have died since human immunodeficiency virus (HIV) was first recognized in 1981 (source: UNAIDS, December 2005), and the new infection rate continues to grow at an alarming rate. Despite medical advances, the worldwide pandemic continues to claim more than 3.1 million lives each year (source: UNAIDS, December 2005). Additional safe and effective treatments are desperately needed for the estimated 40 million adults and children living with HIV as of 2005. IR103 is a second-generation HIV immunotherapy based on the Company’s patented, whole-inactivated virus technology, which was co-invented by Dr.…